fibrinogen

fibrinogen

1. NMR active fibrinogen derivative

(核)磁共振活性纤维蛋白原衍生物

2. PRITHROMBIN TIME DERIVED FIBRINOGEN DETERMINATION ON SYSMEX CA-1500.

pt衍生法测定纤维蛋白原在CA1500上的应用

3. The RBC's here have stacked together in long chains.This is known as "rouleaux formation" and it happens with increased serum proteins, particularly fibrinogen and globulins.

RBC成叠连状，称为“缗钱壮红细胞”，当血清蛋白质，特别是纤维蛋白原和球蛋白增加时出现。

4. In the diabetic patients, the plasma levels of TM were positively correlated with fasting plasma glucose(FPG), blood urea nitroge(BUN), creatinine(Cr), fibrinogen(FIB),urine microalbumin(UMA) and diabetic refinopathy(DR).

TM与空腹血糖(FPG)、血尿素氮(BUN)、肌酐(Cr)、纤维蛋白原(FIB)、尿微量白蛋白(UMA)、糖尿病视网膜病变(DR)呈正相关;

5. a rare congenital disorder of blood coagulation in which no fibrinogen is found in the blood plasma

一种罕见的先天性血液凝固混乱症

6. a rare congenital disorder of blood coagulation in which no fibrinogen is found in the blood plasma.

一种罕见的先天性血液凝固混乱症。

7. Study of serum C-reactive protein or fibrinogen and coronary lesions in patients with unstable angina pectoris

不稳定型心绞痛患者冠脉血管病变与血清C-反应蛋白、纤蛋白原的关系研究

8. The increased levels of fibrinogen and homocysteine seen in relation to secondhand smoke exposure were equivalent to 30% to 45% of those seen for active smoking.

与二手烟有关的纤维素原和同型半胱氨酸水平增加约等于这两个生物标记物在吸烟时水平的30%到50%。

9. the hydrolization of fibrinogen or plasminogen;

二是水解血纤维蛋白或纤溶酶原;

10. Poisoning by human fibrinogen

人纤维蛋白原中毒

11. They also measured blood leels of the inflammatory markers interleukin (IL)-6, C-reactie protein (CRP), and fibrinogen.

他们也检测了炎症标记物白介素-6、C-反应蛋白和纤维蛋白原的血浆水平。

12. low molecular weight fibrinogen degradation products

低分子量纤维蛋白原降解产物

13. Objective To observe the effect of hyperbaric oxygen(HBO) on D-dimer(D-D) and fibrinogen(Fg) in the blood plasma of ischemic apoplexy patients.

作者单位：南京医科大学附属常州第二人民医院高压氧科;

14. If another fetal continue to grow growth is good, level of fibrinogen of pregnant mother plasma is stable, can continue to observe.

倘若另一胎儿继续生长发育良好，孕母血浆纤维蛋白原水平稳定，可以继续观察。

15. Partial correlation analysis showed that plasma fibrinogen was positively correlated with C reactive protein. (r =0.592, P<0.01).

偏相关分析显示,急性心肌梗死患者FIB与CRP明显相关,相关系数r=0.592,P<0.01。

16. Relationship between plasma fibrinogen and cardiovascular risk factors in apparently healthy Chinese subjects

健康人群血浆纤维蛋白原与心血管危险因素的关系

17. Keywords Fibrinogen;Clauss method;Thermal turbidimetry;

关键词纤维蛋白原;克劳斯法;热浊度法;

18. Keywords Hyperlipidemia;C reactive protein;Fibrinogen;Antilipemic agents;

关键词高脂血症;C-反应蛋白;纤维蛋白原;调血脂药;

19. Keywords Intimal proliferation;Vascular remodeling;Angioplasty;Verapamil;Plasma fibrinogen;

再狭窄;血管成形术;纤维蛋白原;维拉帕米;

20. Keywords Coronary heart disease;Fibrinogen;Relativity;

冠心病;纤维蛋白原;相关性;

21. Relationship between Serum Advanced Fibrinogen and Activity of Blood Platelet Membrane Glycoprotein Receptor

冠心病患者纤维蛋白原浓度与血小板膜糖蛋白受体活性表达

22. Correlation of degree of coronary artery pathologic change with fibrinogen in CHD patients

冠心病患者血浆纤维蛋白原与冠状动脉病变程度的相关性研究

23. The Change of Serum Lipoprotein and Fibrinogen in Patients with Different Degree of Coronary Artery Stricture

冠状动脉不同程度狭窄时血脂载脂蛋白和纤维蛋白原变化

24. Cryodesiccant Human Fibrinogen

冻干人纤维蛋白原, 人血纤维蛋白原, 纤维蛋白原[促凝血药]

25. Keywords Phospholipase A_2;Coagulant activity;Fibrinogen;Thrombin-like;Serine protease;

凝血活性;纤维蛋白原;类凝血酶;丝氨酸蛋白酶;

26. Thrombin is an enzyme that catalyzes the conversion of the soluble plasma protein fibrinogen to the insoluble protein fibrin.

凝血酶能催化可溶性血浆纤维蛋白转化为不溶性的纤维蛋白。

27. Intima-injury model was made. On fibrinogen and collagen,platelet adhesion on area of experimental group was lower than that in negative control group(P<0.01).

分别以纤维蛋白原和胶原蛋白膜模拟创伤表面,两实验组血小板粘附率均明显低于阴性对照组,P<0.01;

28. Clinical significance of blood platelet count and serum fibrinogen in patients with ovarian carcinoma

卵巢恶性肿瘤患者血浆纤维蛋白原及血小板四项参数检测的临床意义

29. To fibrin therapeutic use extracted from the venom of the anticoagulant effect of a substance, can be reduced fibrinogen and blood viscosity, for the treatment of arteriovenous thrombosis was good results.

去纤维蛋白治疗应用从蛇毒中提取的一种抗凝作用的物质，可以降低纤维蛋白原和血液粘度，用以治疗动静脉血栓获得良好效果。

30. The improvement extent of high spear of whole blood viscosity, plasma viscosity, fibrinogen, time value ...

另外,观察中发现,两组临床症状、体征均有一定改善,治疗组优于对照组。

31. Meanwhile, the patients" blood sugar blood fat HbAlc fibrinogen abated obviously, the difference was significant compared to the control group (P<0.01 ).

同时患者的血糖、血脂、糖化血红蛋白和纤维蛋白原均较治疗前明显下降，与对照组比较有显著性差异(P＜0.05)。

32. APTT, ELT and fibrinogen were determined.

同时测定APTT、ELT和血浆纤维蛋白原的含量。

33. The transcription protein of down-regulated genes related to degradation of fibrinogen, and to production of protooncogene.

在表达下调的基因中其转录产物涉及纤维蛋白原的降解、原癌基因产物的生成等。

34. The concentrations of cefoperazone sodium, chloromycetin, ciprofloxacin lactate and gentamycin sulfate showed significant influence on the coagulation time and detection rate of fibrinogen in plasma.

头孢哌酮钠、氯霉素、乳酸环丙沙星、硫酸庆大霉素等抗菌素及其浓度变化对血浆中纤维蛋白原的凝固时间和检出率有显著影响。

35. Antibody coated bacteria(ACB),lysozyme(Lys)and fibrinogen degradation pro-

对220例尿路感染作尿抗体包裹细菌(ACB)溶菌酶(Lys)及纤维蛋白降解产物(FDP)检查的结果,表明Lys 与ACB 及FDP 与ACB 符合率分别为77.7%和76.5%。

36. Their ages, sexes, the levels of lipid, fibrinogen and blood glucose, fever, leukocytosis, mean arterial pressure, diabetes history and signs of early cerebral infarction on CT were compared.

对两组患者的年龄、性别、血脂水平、血纤维蛋白原水平、血糖水平、发热、白细胞增多、平均动脉压、糖尿病史和CT早期梗死征象进行比较。

37. In spite of the relatively small number of patients, the clinical results are relevant because they were confirmed by the results of the fibrinogen test.

尽管受试患者的数量相对较少，该临床研究的结论是可信的，因为其结论通过纤维蛋白原测试得到了进一步论证。

38. freeze-dried human fibrinogen

干燥人纤维蛋白原

39. John Danesh,Lewington,Dphil,et al.lasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality[J].JAMA,2005,294,1799.

张剑,韩雅玲,康建,等.纤维蛋白原与冠心病类型、危险因素及病变的相关性[J].心脏杂志,2003,15(2):134.

40. Keywords non-valvular atrial fibrillation;fibrinogen;D-dimer;left atrium;

心房纤颤;纤维蛋白原;D-二聚体;左心房;

41. Keywords unstable angina pectoris;fibrinolysin;fibrinogen;

心绞痛;不稳定型;纤溶酶;纤维蛋白原;

42. When the cruor inside blood-vessel of chronic dispersion sex, but because use up with generate achieve dynamic balance and the fibrinogen drops not apparent.

慢性弥散性血管内凝血时，可因消耗与生成达到动态平衡而纤维蛋白原下降不明显。

43. Keywords Raman spectroscopy;gastritis;gastric ulcer;Fibrinogen;Spermine;

拉曼光谱;精胺;纤维蛋白原;胃炎;胃溃疡;

44. Abstract Purpose: To study the effects of glycol mannate sulfate(GMS) on platelet aggregation and adhesion,bleeding time and fibrinogen.

摘 要 目的： 研究单甘酯对血小板聚集、粘附功能及出血时间和纤维蛋白原含量的影响。

45. Objective To explore the influence of concentrations of common antibiotics on the fibrinogen in plasma.

摘要目的研究4种常用抗菌素的浓度对血浆纤维蛋白原的影响。

46. Objective To observe the effect of Cinepazide Maleate injection (CMI) on hemorheology and fibrinogen in patients with acute cerebral infarction (ACI).

摘要目的观察马来酸桂哌齐特注射液对急性脑梗死病人血液流变学指标和纤维蛋白原的影响。

47. radioactive fibrinogen uptake test

放射性纤维蛋白原摄取试验

48. Method: According to inspecting the whole blood low specific viscosity,the index of aggregation of RBC,ESR,fibrinogen,TG and HBA_ 1c on DE,DM and NS.

方法 :分别对糖尿肠病组 (DE)、糖尿病组 (DM )、健康人组 (NS)进行了低切变率下全血粘度、红细胞聚集指数、血沉、纤维蛋白原、甘油三酯及糖化血红蛋白指数的检测。

49. Methods According to ICSH and NCCLS documents,precision,accuracy,carryover pollution rate and anti-interference of prothrombin time,activated partial prothrombin time,thronbin time and fibrinogen on the instrument were examined.

方法 参照 ICSH和 NCCLS有关文献对该仪器所检测的凝血酶原时间、活化部分凝血酶原时间、凝血酶时间及纤维蛋白原等项目作了精密度、准确性、交叉污染率和抗干扰能力测试。

50. Methods Activities of tissue type plasminogen activator(t PA) and plasminogen activator inhibitor(PAI) and contents of D dimeter(D D) and fibrinogen(FbG) were determined in 22 patients with TIA and compared with 22 normal controls.

方法 对 2 2例颈内动脉系统TIA患者血浆组织型纤溶酶原激活物 (t PA)及其快速抑制物 (PAI)的活性、D 二聚体 (D D)及纤维蛋白原 (FbG)含量进行检测 ,并与对照组进行比较。

51. Method: Make a comparison of hemorheological index,fibrinogen as well as the number of platelets between 98 elder patients with malignant tumors and 40 healthy counterparts.

方法:对98例老年恶性肿瘤患者及40例健康老年人血液流变学指标、血小板计数、纤维蛋白原指标进行比较。

52. Methods:Anticoagulant activity was determined by measuring prothrombin time(PT),thrombin time(TT),activated partial throboplstin time(APTT) and fibrinogen coagulation time(FCT).

方法:测定水蛭乙醇提取物不同萃取部位对凝血酶原时间(PT),凝血酶时间(TT),活化的部分凝血活酶时间(APTT),纤维蛋白原凝固时间(FCT)的影响。

53. Methods: The changing of platelet aggregation rate, the thrombus weight, the content of fibrinogen and the euglobulin lysis time were determined after SEF iv on rabbit and mice.

方法:采用全蝎提取液给家兔、小鼠静脉注射,并测定其血小板最大聚集率、血栓重量、纤维蛋白原含量及优球蛋白溶解时间的变化。

54. Methods To measure plasma prothrombin time (PT), activate part plasma prothrombin time (APTT), prothrombin time (TT) and fibrinogen(FIB) in 49 cases type 2 diabetics and 30 cases normal controls.

方法利用全自动血凝仪检测30例正常健康体检者及49例2型糖尿病患者的PT、APTT、TT及FIB值。

55. Methods The blood pressure,blood glucose,blood lipid(cholesterol,glyceryltrioleate)and fibrinogen of 60 cases of PS were analyzed retrospectively and treated with statistics.

方法回顾性分析了60例进展性脑梗死患者的血压、血糖、血脂及纤维蛋白原指标,并进行统计学处理。

56. Method ESR, hematocrit and plasma fibrinogen level of 445 middle age and elder male and female individuals were examined and dynamic ESR analysis to all subjects was performed.

方法对445例无活动性炎症的男女性中老年成人检测ESR-K、血浆纤维蛋白原及红细胞压积，并作动态ESR分析。

57. Methods: 50 patients with TIA and 50 controls from the health were performed overnight polysomnography as well as blood routine, lipidemia, blood viscosity and fibrinogen.

方法对TIA患者和健康对照组各50例进行整夜多导睡眠检测，以及血常规、血脂、血黏度、纤维蛋白原检测。

58. Methods The levers of plasma fibrinogen and hematocrit were measured in 30 normal subjects 60 diabetics without microangiopathy and 64 diabetics with microangiopathy.

方法按统一要求测定124例糖尿病患者及30例正常人的血浆纤维蛋白原和红细胞比积。

59. Methods 60 cases of ischemic cerebrovascular disorder(both acute and decubation)and 20 normal controls were tested for plasma fibrinogen,and the results were analyzed.

方法检测60例缺血性脑卒中患者(急性期和恢复期)及20名正常对照者血浆中纤维蛋白原浓度,进行比较分析。

60. Methods Add the cefoperazone sodium, chloromycetin, ciprofloxacin lactate and gentamycin sulfate at different concentrations into plasma and determine the coagulation time and content of fibrinogen.

方法采用凝固法，以加入抗菌素后血浆中纤维蛋白原的凝固时间为指标，观察不同浓度的头孢哌酮钠、氯霉素、乳酸环丙沙星和硫酸庆大霉素对血浆纤维蛋白原的影响。

61. Methods: Platelet aggregation was measured by turbidimetry,adhesion was indicated by platelet retention rate obtained from spinning glass bottle and fibrinogen was analysed by colorimetry.

方法： 比浊法观察血小板聚集功能，玻瓶法观察血小板粘附功能，小鼠剪尾法观察出血时间，比色法测定纤维蛋白原含量。

62. Plasma fibrinogen was measured in 82 healthy persons, 46 patients with coronary heart disease(CHD) uiagnosed by coronary arteriography, and 15 patients with acute myocardial infarction(AMI).

本文测定正常人82名、经冠状动脉造影诊断的冠心病(CHD)患者46例、急性心肌梗塞(AMI)患者15例的血浆纤维蛋白原含量。

63. The effects of ticlopidine on platelet aggregation(PAg) and plasma fibrinogen(Fg) level were investigated and compared with those of acetylsalicylic acid(ASA) in patients with coronary artery disease(CAD).

本研究对冠心病患者应用噻氯吡啶对血小板聚集功能（plateletaggregation，PAg）及血浆纤维蛋白原（fibrinogen，Fg）水平的影响进行探讨并与乙酰水杨酸（acetylsalicyliaacid，ASA）进行比较。

64. NMR-active fibrinogen derivative

核磁共振活性纤维蛋白原衍生物

65. Prothrombin time (PT), international normalized ratio (INR), partially activated thromboplastin time (APTT) and fibrinogen (FIB) were detected.

检测凝血酶原时间(PT)、凝血酶原时间国际标准化指数(INR)、部分活化凝血酶原时间(APTT)和纤维蛋白原浓度(FIB)。

66. This new polysaccharide derived material enhances the fibrinogen clottability for haemostatic action and becomes hydrogel as a separation barrier after contacting with body liquid for anti-adhesion.

止血防粘连生物纸是一种采用天然多糖交链制成的新型可降解止血防粘连材料,具有纤维蛋白原活性增强作用和吸水后呈水凝胶结构起到隔离防粘连作用。

67. Keywords hirudin;fibrinogen;thrombin;determination of activity;

水蛭素;纤维蛋白原;凝血酶;活性测定;

68. Fibrinogen and cruor zymogen time should be checked before cure, under normal person unfavorable application.

治疗前应检查纤维蛋白原及凝血酶原时间，低于正常者不宜应用。

69. Before and after treamet, levels of mean pulmonary artery pressure (mPAP), plasma endothelin (ET) - 1, fibrinogen(Fg) and D -dirner(D-D) were measured.

测定两组治疗前后平均肺动脉压(mPAP)、血浆内皮素-1(EF-1)、纤维蛋白原(Fg)及D-二聚体(D-D)水平。

70. Influence Exerted by Qinggong Zhixue Granule on The Content of Rabbits'Fibrinogen and Mice's Mesentery Microcirculation

清宫止血颗粒对家兔纤维蛋白原含量与小鼠肠系膜微循环的影响

71. Changes of rheoencephalogram,blood rheology and fibrinogen were observed before and after the treatments and clinical improvements for two therapies were evaluat-ed.

然后，对63例病人联合用药，同样在治疗前、后做脑血流图、血流变学和纤维蛋白原检查进行分析，最后对两组病人进行临床疗效的对比分析。

72. ADSORPTION OF FIBRINOGEN ON THE SURFACES OF BIOMATERIALS STUDIED BY USING SURFACE PLASMON RESONANCE (SPR) SENSOR

用SPR生物传感器研究纤维蛋白原在生物医用材料表面的吸附

73. Detection of staphylococcal clumping factor with purified fibrinogen

用纯化纤维蛋白原检测葡萄球菌凝聚因子

74. Results:The abnormal hemorheology was improved,and fibrinogen was decrease after treatment.

用血塞通治疗后血液流变学各指标有显著性改善,血液纤维蛋白原含量降低。

75. The plasma fibrin D-dimer was measured using enzyme linked immunoassay. Fibrinogen(Fg) and hs-CRP were measured.

用酶联免疫吸附法测定血浆D-二聚体、用全自动血凝分析仪测定血浆Fg、用免疫浊度法测定hs-CRP。

76. For detecting the process of reaction between Bromelain and Fibrinogen, quantum dots synthesized in aqueous solution were used to label bromelain in order to form CdTe-Bromelain.

用量子点标记菠萝蛋白酶,以此为荧光探针,监测其与纤维蛋白原的反应过程.实验结果表明,随着反应时间的增加,荧光光谱逐渐蓝移,荧光强度也逐渐下降

77. Since fibrinogen is derived from human body, the physician must evaluate the risk that serum hepatitis may follow its use.

由于“纤维蛋白原”来自人血，医生必须估计到使用本品后可能引起血清肝炎的危险性。

78. Fibrinogen and Albumin Levels and Risk of Atrial Fibrillation in Men and Women(the Copenhagen City Heart Study)

男性和女性房颤发生风险与纤维蛋白原及白蛋白水平的关系:哥本哈根市心脏研究

79. White blood cells, platelets, fibrinogen, and coagulation factors were decreased during the early stage of plasma separation and appeared to be ...

白细胞、血小板和四种凝血因子在分离开始时都有不同程度地减少,但均在临床允许的范围内。

80. Three skin biopsies demonstrated degeneration of fibrinogen, perivenous infiltration of inflammatory cells.

皮肤活检3例示胶原变性，小静脉周围可见炎性细胞浸润。